Entrada Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2021 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Entrada Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2021 to Q2 2024.
  • Entrada Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 31, 2024 was 37.2M shares, a 11.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 37.2M +3.93M +11.8% Jul 31, 2024 10-Q 2024-08-13
Q1 2024 33.6M +404K +1.22% Mar 6, 2024 10-K 2024-03-13
Q3 2023 33.4M +1.96M +6.25% Oct 31, 2023 10-Q 2023-11-07
Q2 2023 33.3M +1.9M +6.07% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 33.2M +1.83M +5.84% Apr 30, 2023 10-Q/A 2023-08-08
Q3 2022 31.4M Oct 31, 2022 10-Q 2022-11-07
Q2 2022 31.4M Jul 31, 2022 10-Q 2022-08-11
Q1 2022 31.4M Apr 30, 2022 10-Q 2022-05-12
Q4 2021 31.2M Nov 30, 2021 10-Q 2021-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.